3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
21
Rectal Neoplasms
10
Colonic Neoplasms
6
Pancreatic Neoplasms
4
Stomach Neoplasms
3
Neoplasm Metastasis
3
Adenocarcinoma Of Esophagus
3
Peritoneal Neoplasms
2
Neoplasms
2
Liver Neoplasms
2
Esophageal Neoplasms
2
Pancreatic Adenocarcinoma
1
Ovarian Neoplasms
1
Neuropathy, Painful
1
Neuralgia
1
Neoplasm Recurrence, Local
1
Malignant Solid Tumour
1
Locally Advanced Pancreatic Carcinoma(LAPC)
1
Gallbladder Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Disease Progression
1
Cold Hypersensitivity
1
Cholangiocarcinoma
1
Carcinoma, Hepatocellular
1
Carcinoma, Basal Cell
1
Breast Neoplasms
1
Bile Duct Neoplasms
1
Advanced Rectal Cancer
1
Advanced Primary Liver Cancer
1
Adenocarcinoma of the Lower Rectum
1
Interventions
Carboplatin
23
Cisplatin
19
pembrolizumab
14
Paclitaxel
12
Gemcitabine
12
Pemetrexed
11
130-nm albumin-bound paclitaxel
9
Everolimus
8
Cetuximab
8
Fluorouracil
7
Axitinib
6
osimertinib
5
durvalumab
5
Sunitinib
5
Radiotherapy
5
Erlotinib Hydrochloride
5
Docetaxel
5
Cyclophosphamide
5
Albumin-Bound Paclitaxel
5
Sorafenib
4
Radiation
4
Nivolumab
4
Ipilimumab
4
vosaroxin
3
Radiotherapy, Intensity-Modulated
3
Octreotide
3
Irinotecan
3
Bevacizumab
3
1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine
3
pralsetinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma
×
Folfox protocol
×
Clear all
No trials found.